451 related articles for article (PubMed ID: 9642098)
21. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
22. [Construction and application of retroviral vector system useful for high-efficiency transfection into human T cells].
Zhang RP; Yun L; Peng L; Lu B; Zhou Q; Wang H; Guo YJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):420-2, 426. PubMed ID: 16805997
[TBL] [Abstract][Full Text] [Related]
23. Simplified generation of high-titer retrovirus producer cells for clinically relevant retroviral vectors by reversible inclusion of a lox-P-flanked marker gene.
Loew R; Selevsek N; Fehse B; von Laer D; Baum C; Fauser A; Kuehlcke K
Mol Ther; 2004 May; 9(5):738-46. PubMed ID: 15120335
[TBL] [Abstract][Full Text] [Related]
24. Green fluorescent protein retroviral vectors: low titer and high recombination frequency suggest a selective disadvantage.
Hanazono Y; Yu JM; Dunbar CE; Emmons RV
Hum Gene Ther; 1997 Jul; 8(11):1313-9. PubMed ID: 9295126
[TBL] [Abstract][Full Text] [Related]
25. Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods.
Sastry L; Johnson T; Hobson MJ; Smucker B; Cornetta K
Gene Ther; 2002 Sep; 9(17):1155-62. PubMed ID: 12170379
[TBL] [Abstract][Full Text] [Related]
26. Use of a herpes thymidine kinase/neomycin phosphotransferase chimeric gene for metabolic suicide gene transfer.
Candotti F; Agbaria R; Mullen CA; Touraine R; Balzarini J; Johns DG; Blaese RM
Cancer Gene Ther; 2000 Apr; 7(4):574-80. PubMed ID: 10811475
[TBL] [Abstract][Full Text] [Related]
27. [Packaging and concentrating of high titer of retrovirus containing IL-4RA].
Wang GL; Liu XT; Lu JR
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Sep; 11(9):761-4. PubMed ID: 19755029
[TBL] [Abstract][Full Text] [Related]
28. Efficient transduction and selection of human T-lymphocytes with bicistronic Thy1/HSV1-TK retroviral vector produced by a human packaging cell line.
Lemoine FM; Mesel-Lemoine M; Cherai M; Gallot G; Vié H; Leclercq V; Trébèden-Negre H; Mammès O; Boyer O; Noguiez-Hellin P; Klatzmann D
J Gene Med; 2004 Apr; 6(4):374-86. PubMed ID: 15079812
[TBL] [Abstract][Full Text] [Related]
29. Production of increased titer retrovirus vectors from stable producer cell lines by superinfection and concentration.
Parente MK; Wolfe JH
Gene Ther; 1996 Sep; 3(9):756-60. PubMed ID: 8875222
[TBL] [Abstract][Full Text] [Related]
30. The selectable marker neo gene down-regulates gene expression from retroviral vectors containing an internal ribosome entry site.
Byun J; Kim JM; Robbins PD; Kim S
Gene Ther; 1998 Oct; 5(10):1441-4. PubMed ID: 9930351
[TBL] [Abstract][Full Text] [Related]
31. [Construction and identification of recombinant retroviral vector and stable cell line expressing latent membrane protein 2A of Epstein-Barr virus].
Chen Y; Zhou F; Sun BC; Liu GY; Wang B; Yao K
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Nov; 25(11):1013-5. PubMed ID: 19900370
[TBL] [Abstract][Full Text] [Related]
32. Production of retroviral vectors.
Miller AD
Curr Protoc Hum Genet; 2001 May; Chapter 12():Unit 12.5. PubMed ID: 18428250
[TBL] [Abstract][Full Text] [Related]
33. Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector.
Feng M; Jackson WH; Goldman CK; Rancourt C; Wang M; Dusing SK; Siegal G; Curiel DT
Nat Biotechnol; 1997 Sep; 15(9):866-70. PubMed ID: 9306401
[TBL] [Abstract][Full Text] [Related]
34. Characterization of transient expression system for retroviral vector production.
Hotta A; Saito Y; Kyogoku K; Kawabe Y; Nishijima K; Kamihira M; Iijima S
J Biosci Bioeng; 2006 Apr; 101(4):361-8. PubMed ID: 16716946
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of ovarian cancer cells transduced by the bicistronic retroviral vector containing GM-CSF and HSV-TK genes.
Guan J; Ma L; Wei L
Chin Med J (Engl); 2001 Feb; 114(2):147-51. PubMed ID: 11780195
[TBL] [Abstract][Full Text] [Related]
36. Suspension packaging cell lines for the simplified generation of T-cell receptor encoding retrovirus vector particles.
Reuss S; Biese P; Cosset FL; Takeuchi Y; Uckert W
Gene Ther; 2007 Apr; 14(7):595-603. PubMed ID: 17235289
[TBL] [Abstract][Full Text] [Related]
37. Development and characterization of a minimal inducible packaging cell line for simian immunodeficiency virus-based lentiviral vectors.
Kuate S; Wagner R; Uberla K
J Gene Med; 2002; 4(4):347-55. PubMed ID: 12124977
[TBL] [Abstract][Full Text] [Related]
38. Sub-retroviral particles as gene transfer vectors that by-pass retrovirus-receptor interaction restrictions.
Janka I; Günzburg WH; Brem G; Erfle V; Salmons B
Biochem Mol Biol Int; 1993 Oct; 31(2):349-57. PubMed ID: 8275023
[TBL] [Abstract][Full Text] [Related]
39. Increased gene transfer into human CD34+ progenitor cells using retroviral vectors produced by a canine packaging cell line.
Bauer G; Sauter S; Ibanez C; Rice CR; Valdez P; Jolly D; Kohn DB
Biol Blood Marrow Transplant; 1998; 4(3):119-27. PubMed ID: 9923409
[TBL] [Abstract][Full Text] [Related]
40. A stable system for the high-titer production of multiply attenuated lentiviral vectors.
Klages N; Zufferey R; Trono D
Mol Ther; 2000 Aug; 2(2):170-6. PubMed ID: 10947945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
